Nabriva Therapeutics plc Total Non Current Liabilities 2011-2026 | NBRV

Annual Total Non Current Liabilities Nabriva Therapeutics plc

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
867 K	5.22 M	6.78 M	36.2 M	24 M	435 K	107 K	84.2 K	6.38 M	9.88 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
36.2 M	84.2 K	8.99 M

Quarterly Total Non Current Liabilities Nabriva Therapeutics plc

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
697 K	867 K	977 K	-	4.88 M	5.22 M	6.11 M	7 M	6.12 M	6.78 M	6.78 M	6.78 M	6.78 M	36.2 M	36.2 M	36.2 M	36.2 M	24 M	24 M	24 M	24 M	435 K	435 K	435 K	435 K	107 K	107 K	107 K	107 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36.2 M	107 K	10.8 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Verastem VSTM	108 M	$ 5.04	-4.73 %	$ 349 M	USA
VistaGen Therapeutics VTGN	4.16 M	$ 0.57	-5.87 %	$ 17.6 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Adaptive Biotechnologies Corporation ADPT	263 M	$ 12.41	-11.1 %	$ 1.88 B	USA
Xenon Pharmaceuticals XENE	12.3 M	$ 54.48	-1.89 %	$ 4.24 B	Canada
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
ChemoCentryx CCXI	81.7 M	-	-	$ 3.74 B	USA
Enochian Biosciences ENOB	425 K	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Summit Therapeutics SMMT	5.71 M	$ 16.58	-3.94 %	$ 12.4 B	Britain
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
Alnylam Pharmaceuticals ALNY	604 M	$ 317.36	-3.29 %	$ 41.6 B	USA
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.29	-3.6 %	$ 822 M	Canada
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
Fusion Pharmaceuticals FUSN	4.31 M	-	-	$ 1.41 B	Canada
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 19.01	-2.66 %	$ 889 M	USA
Gritstone Oncology GRTS	30.5 M	-	0.42 %	$ 213 M	USA
Завод ДИОД DIOD	89.5 M	-	-	-	Russia
Фармсинтез LIFE	13.2 M	-	-	-	Russia
ACADIA Pharmaceuticals ACAD	49.6 M	$ 20.75	-3.35 %	$ 3.44 B	USA
Aligos Therapeutics ALGS	15 M	$ 6.66	-5.4 %	$ 65.8 M	USA
Teligent, Inc. TLGT	142 M	-	-13.85 %	$ 16.1 M	USA
Viela Bio, Inc. VIE	1.38 M	-	-	$ 2.91 B	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Alkermes plc ALKS	329 M	$ 29.39	-1.77 %	$ 4.84 B	Irlanda
Cabaletta Bio CABA	43.9 M	$ 2.68	-4.96 %	$ 269 M	USA
AbbVie ABBV	81.7 B	$ 209.4	-0.81 %	$ 370 B	USA
AbCellera Biologics ABCL	326 M	$ 3.27	-2.39 %	$ 977 M	Canada
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA